ARTICLE | Company News
J&J partners with Wellcome Trust, KU Leuven for dengue
August 30, 2013 11:58 PM UTC
The Janssen Pharmaceuticals Inc. subsidiary of Johnson & Johnson (NYSE:JNJ) partnered with the Wellcome Trust and the Catholic University of Leuven (KU Leuven) to discover and develop antivirals to tr...